Waterford-based pharmaceuticals company Haleon saw profits at its sales division grow to €1.4 million in 2024.

The company generated all of its €53.3 million revenue in Europe and in the consumer healthcare sector, and has reported back-to-back increases in turnover in recent years.

Haleo

📰

Continue Reading on The Irish Times

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →